Organic Chemistry TRIZ Cases

Six-step buprenorphine synthesis using Diels-Alder reactions and controlled alkylation to produce high-purity alkaloids.

Optimized quinoline derivatives inhibit MELK kinase to address the lack of effective treatments for cancers with high enzyme expression.

A sulfur-containing polyol forms a polyurethane primer that bonds metal reinforcements to rubber matrices without cobalt salts.

Incorporating reversibly cross-linkable agents into polystyrene foam creates a thermally stable network that resists degradation at elevated temperatures.

Substituted pyrene compounds optimize the HOMO-LUMO gap to deliver blue light with high color purity, low driving voltage, and extended device lifetime.

A nitrogen-containing heteroaromatic host material enables efficient layer formation via coating methods for organic electroluminescence devices.

Specific compounds inhibit Cathepsin K-mediated bone resorption, addressing the lack of effective therapies for osteoporosis and related skeletal conditions.

Strong electron-withdrawing groups on the fluorenone core reduce singlet-triplet energy gaps, extending device lifespan.

Compounds degrade BRD9 protein levels via proteasomal pathways.

Cannabinoid receptor modulators combined with terpenes modulate the endocannabinoid system to alleviate acute toxicity symptoms.

Spirocyclically substituted 1,3-propane dioxide derivatives overcome insufficient GPR40 activation by optimizing molecular binding affinity.

A light absorber layer integrates pyrene, chrysene, or anthracene compounds to shield organic electroluminescence devices from external radiation.

Chemical Formula 1 compound improves OLED efficiency and lifetime by optimizing molecular structure to reduce driving voltage.

Replacing chromatographic purification with crystallization of salt-form intermediates improves dabigatran purity and yield.

Carbodiimide activation of benzoic acid derivatives enables amide bond formation with inorganic bases, eliminating genotoxic acid chloride intermediates.

A TADF host and formula 2 emitting material narrow the full width at half maximum of blue light while maintaining high efficiency.

Solid acid catalysts enable high glycerol conversion at low temperatures, eliminating solvent-intensive azeotropic distillation steps.

Bicyclic amines inhibit CDK2 to overcome resistance in cancers deregulated by uncontrolled cell proliferation.

Fused pentacyclic imidazole derivatives overcome limited structural diversity of macromolecular agents by providing potent TNFα modulation.

Composite organic compounds absorb near-infrared light, resolving silicon pixel size constraints while maintaining high sensitivity.

Polar functional groups modify film thickness to maintain lithium ion conductivity while preventing electrolyte decomposition at high temperatures.

A method preparing d-glucaro-1,4:6,3-dilactone using an organic acid and cation exchange resin to produce high purity product.

Specific small molecule compounds stabilize the TLR8 preformed dimer, suppressing autoimmune responses without broad immunosuppression.

Selective thienobenzoxazepine compound increases total sleep time without causing REM inhibition or rebound insomnia.

Heterobifunctional molecules resolve non-specific enzyme control by recruiting acetylation enzymes to target proteins, enabling precise protein acetylation.

A nitrogen-containing heteroaromatic compound serves as a host material to facilitate balanced carrier migration and exciton recombination.

A therapeutic compound inhibits mitochondrial pyruvate carrier and monocarboxylate transporter 1 to treat metabolic diseases.

Multi-target inhibitors block ASCT2 and related pathways to prevent compensatory uptake in melanoma and lung cancer.

Segmented polymer-bound and free photoacid generators in a photoresist composition resolve acid diffusion non-uniformity while maintaining high resolution.

Segmented polymer architecture combines hydrophilic blocks with catechol-functionalized segments to enable water solubility and metal coordination.

Novel deoxygalactonojirimycin derivatives substituted with biphenyl groups inhibit glucosylceramide synthase.

Selective compounds activate TGR5 and inhibit FXR to improve glucose tolerance in obesity-related metabolic issues.

Sequential photochemical reactions resolve synthesis efficiency versus isomer selectivity to yield rigidified polycyclic systems.

Replacing expensive reagents with acetaldehyde and formic acid eliminates side reactions and tar generation, achieving 95% yield.

Esterification of quercetin with fatty acids resolves low solubility and rapid metabolism, enhancing anti-neoplastic effects.

Removing ortho-phenylenediamine formation from HDAC inhibitors eliminates toxic metabolite generation while maintaining enzyme inhibition efficacy.

Small molecule compounds selectively activate the granulocyte colony-stimulating factor receptor to treat hematopoietic disorders.

Piperazine and piperidine derivatives inhibit voltage-dependent anion channel oligomerization.

A quinoxaline derivative with electron-trapping properties controls carrier balance in the light-emitting element.

Novel 6-substituted and 7-substituted morphinan analogs modulate opioid receptors to provide targeted analgesic action.

Pendant lithium perfluoroethyl sulfonates on aromatic backbones eliminate anion mobility and concentration polarization in single-ion electrolytes.

Segmented pyrrolo[2,3-d]pyrimidin-4-yl structures increase inhibition potency while managing compound design complexity for autoimmune treatment.

Formula A compounds disrupt the CD95 PLCγ1 interaction to reduce Th17 trafficking and alleviate clinical symptoms in lupus-prone mice.

Movable holding claws grip the wafer circumference while allowing light to pass through the notch, eliminating re-holding cycles and boosting throughput.

Dissolving RDX in supercritical dimethylether and decompressing the solution to form fine spherical particles.